stockrow
Friday 6 November 2026
Export MD’s income statement to Excel — free account
Pediatrix Medical Group, Inc.
MD Healthcare Medical Care Facilities
Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024.
- Revenue
- +1.72%
- EPS
- −27.6%
- Free cash flow
- −14.4%
- Total debt
- −4.11%
Quarter to September 2026, against a year earlier
31.73
1.07
−3.26%
Follow MD
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
13.85 | 12.12 | 10.38 | 11.03 |
+8 more quarters Free account |
P/S ratio |
1.01 | 1.03 | 0.90 | 0.94 | |
P/FCF ratio |
9.49 | 8.80 | 7.29 | 7.12 | |
P/Operating CF |
16.95 | 16.06 | (13.32) | 15.76 | |
P/B ratio |
2.34 | 2.28 | 1.97 | 2.08 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.09 | 1.12 | 1.03 | 0.99 | |
EV/EBITDA |
9.04 | 9.17 | 8.24 | 8.19 | |
EV/Operating CF |
9.43 | 8.88 | 7.70 | 6.99 | |
EV/FCF |
10.21 | 9.59 | 8.39 | 7.51 | |
Quick Ratio |
1.24 | 1.28 | 1.28 | 1.62 | |
Current Ratio |
1.28 | 1.32 | 1.33 | 1.66 | |
Net Debt/EBITDA |
2.12 | 2.87 | 5.47 | 1.79 | |
Debt/Assets |
27.00% | 27.42% | 28.54% | 26.59% | |
Debt/Equity |
0.68 | 0.66 | 0.67 | 0.69 | |
Asset Turnover |
0.90 | 0.92 | 0.95 | 0.87 | |
Operating CF/Net income |
2.50 | 3.15 | (4.39) | 3.39 | |
Capex/Depreciation |
(0.69) | (0.24) | (1.00) | (0.90) | |
Interest Coverage |
8.02 | 6.97 | 5.04 | 5.58 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.51% | 12.57% | 12.66% | 13.30% | |
Intangible Assets out of Total Assets |
0.60 | 0.60 | 0.62 | 0.57 | |
Share Based Compensation of Revenue |
1.24% | 1.04% | 0.98% | 1.08% | |
Graham Net Nets |
(0.30) | (0.29) | (0.35) | (0.34) | |
Graham Number |
21.44 | 22.84 | 22.44 | 21.20 | |
Earnings Yield |
7.22% | 8.25% | 9.63% | 9.07% | |
Free Cash Flow Yield |
10.54% | 11.36% | 13.72% | 14.05% | |
Revenue per Share |
6.49 | 6.14 | 5.89 | 5.87 | |
Operating CF per Share |
1.52 | 1.58 | (1.61) | 1.36 | |
Capex per Share |
(0.06) | (0.02) | (0.08) | (0.06) | |
Free Cash Flow per Share |
1.46 | 1.56 | (1.68) | 1.29 | |
Cash per Share |
5.51 | 5.09 | 4.07 | 5.94 | |
Shareholders Equity per Share |
10.99 | 11.09 | 10.86 | 10.30 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.99 | 11.09 | 10.86 | 10.30 | |
Free Cash Flow |
112.93 | 123.94 | (136.09) | 108.82 | |
Working Capital |
148.35 | 158.56 | 144.40 | 304.60 | |
Capital Expenditures |
(4.38) | (1.38) | (6.25) | (5.29) | |
Net Current Asset Value |
(605.73) | (589.22) | (604.68) | (617.33) | |
EV/EBIT |
10.07 | 10.18 | 9.12 | 9.08 | |
Capex to Sales |
0.01 | 0.00 | 0.01 | 0.01 | |
Price to Operating Income |
9.35 | 9.34 | 7.92 | 8.61 | |
| Other line items | |||||
Average Receivables |
237.61 | 242.81 | 244.90 | 257.46 | |
Average Payables |
347.55 | 302.60 | 235.55 | 409.11 | |
Average Assets |
2,169.41 | 2,116.22 | 2,031.89 | 2,199.70 | |
Average Common Equity |
870.14 | 857.37 | 833.88 | 815.40 |
Columns are period end dates · fundamentals updated 2 Nov 2026